Treatment of splenic flexure colon cancer: a comparison of three different surgical procedures: Experience of a high volume cancer center.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 07 2019
29 07 2019
Historique:
received:
22
10
2018
accepted:
11
07
2019
entrez:
31
7
2019
pubmed:
31
7
2019
medline:
28
10
2020
Statut:
epublish
Résumé
Extended right or left hemicolectomy are the most common surgical treatments for splenic flexure colon cancer. Extended resection (including distal pancreasectomy and/or splenectomy), has been often indicated for the treatment for the splenic flexure cancer, because the lymphatic drainage at this site is poorly defined and assumed as heterogeneous. Between January 2006 and May 2016, 103 patients with splenic flexure colon cancer were enrolled in the study. We evaluated the clinicopathological findings and outcomes of all patients and associated them to the different surgical treatment. Out of 103 selected cases an extended right hemicolectomy was performed in 22 (21.4%) patients, an extended left hemicolectomy in 24 (23.3%) patients, a segmental resection of the splenic flexure in 57 (55.3%) patients; the combined resection of adjacent organs showing tumor adherence was carried out in 11 (10.7%) patients. The tumor infiltrated near organs (T4) in 5 patients. No significant differences in complications were found among the three groups. In all groups no differences were found in the total number of harvested lymphnodes. After a median follow-up of 42 months, 30 recurrences and 19 deaths occurred (12 for tumor progression). There was no difference in overall and progression free survival among the three different surgical treatments. According to our results, the partial resection of splenic flexure was not associated with a worse prognosis and it was leading for a satisfactory oncological outcome. It is our opinion that the extended surgery is seldomly indicated to cure splenic flexure cancer.
Identifiants
pubmed: 31358904
doi: 10.1038/s41598-019-47548-z
pii: 10.1038/s41598-019-47548-z
pmc: PMC6662908
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10953Références
Int J Colorectal Dis. 2016 Mar;31(3):623-30
pubmed: 26689401
BMC Gastroenterol. 2015 Jul 07;15:76
pubmed: 26148781
J Natl Cancer Inst. 2007 Mar 21;99(6):433-41
pubmed: 17374833
Int J Colorectal Dis. 2014 Oct;29(10):1223-9
pubmed: 25060216
Dis Colon Rectum. 1987 Nov;30(11):872-4
pubmed: 3677963
J Clin Oncol. 2012 May 20;30(15):1763-9
pubmed: 22473170
Semin Oncol. 2011 Aug;38(4):511-20
pubmed: 21810510
Dis Colon Rectum. 1991 May;34(5):401-3
pubmed: 2022146
Surg Laparosc Endosc Percutan Tech. 2017 Oct;27(5):318-327
pubmed: 28796653
Onco Targets Ther. 2016 Apr 15;9:2203-9
pubmed: 27143915
J Surg Res. 2012 Nov;178(1):172-80
pubmed: 22524976
Ann R Coll Surg Engl. 1956 Oct;19(4):241-56
pubmed: 13363265
Cancer Res Treat. 2010 Jun;42(2):69-76
pubmed: 20622960
Arch Pathol Lab Med. 2009 May;133(5):781-6
pubmed: 19415953
Surg Oncol. 2006 Dec;15(4):243-55
pubmed: 17531744
Int J Colorectal Dis. 2013 Feb;28(2):217-26
pubmed: 22941113
Acta Chir Belg. 2013 Mar-Apr;113(2):107-11
pubmed: 23741929
Surg Today. 2014 Nov;44(11):2045-51
pubmed: 24306213
Surg Today. 2001;31(3):204-9
pubmed: 11318121
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Dis Colon Rectum. 2016 Jul;59(7):630-9
pubmed: 27270515
J Clin Oncol. 2010 Jan 10;28(2):272-8
pubmed: 19949013
Gastroenterology. 2008 May;134(5):1296-310
pubmed: 18471507
Dis Colon Rectum. 2018 Apr;61(4):441-446
pubmed: 29521825
Int J Colorectal Dis. 2012 Jan;27(1):89-93
pubmed: 21850401
Ann R Coll Surg Engl. 2016 May;98(5):303-7
pubmed: 27023638
J Gastroenterol. 2000;35(7):528-35
pubmed: 10905361
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Surg Endosc. 2018 Aug;32(8):3467-3473
pubmed: 29344788
Dis Colon Rectum. 2004 Aug;47(8):1269-84
pubmed: 15484340